Navigation Links
Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives
Date:9/26/2011

SAN DIEGO, Sept. 26, 2011 /PRNewswire/ -- Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, today announced the appointment of Jaisim Shah as Senior Vice President and Chief Business Officer and Pravin Soni, PhD, as Senior Vice President and Chief Technical Officer, both newly created positions. The company also announced that it drew down $17 million from its tranched Series A financing, triggered by positive Phase 2a clinical trial results of its lead product, EP-101, for the treatment of chronic obstructive pulmonary disease. The second part of the financing will help fund an ongoing Phase 2b clinical trial of EP-101 for which data is expected by the end of the first quarter 2012.

"Mr. Shah and Dr. Soni bring strong commercial and technical leadership skills to Elevation," stated Bill Gerhart, President and CEO of Elevation.  "Their addition to the Elevation leadership team significantly enhances our ability to develop and optimally position in the marketplace new inhaled drug therapies that meet significant unmet clinical needs."

Mr. Shah is a senior-level commercial and business development executive with 27 years of experience in business development, commercial operations, investor relations, marketing and medical affairs, including leadership positions at F. Hoffman-LaRoche, Bristol-Myers Squibb and PDL BioPharma.  At Elevation, Mr. Shah will be responsible for all product positioning and business development activities.  Prior to Elevation he was President of Zelos Therapeutics, where he focused on financing and business development. Prior to Zelos, he was the Senior Vice President and Chief Business Officer at CytRx, a biopharmaceutical company.  Prior to CytRx, Mr. Shah was Chief Business Officer at Facet Biotech and PDL BioPharma where he completed numerous licensing/partnering and strategic transactions with pharmac
'/>"/>

SOURCE Elevation Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
2. Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults
3. Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)
4. Valeant Pharmaceuticals Intends to Raise Offer for Afexa Life Sciences Inc. to $0.85 per Share
5. Clermont Pharmaceuticals Reports Positive Phase III Results for Drug to Treat Glaucoma
6. Pacira Pharmaceuticals, Inc. Announces Efficacy and Safety of EXPAREL™ Highlighted at "Hot Topics in Plastic Surgery" Panel at the 2011 Annual Meeting of the American Society of Plastic Surgeons
7. Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products
8. Zacks Industry Outlook Highlights: Vertex Pharma, AstraZeneca, Abbott Labs, Allergan and Onyx Pharmaceuticals
9. Optimer Pharmaceuticals and Astellas Receive Positive Opinion from CHMP for European Approval of DIFICID™
10. Isis Pharmaceuticals Files Patent Infringement Suit Against Santaris Pharma
11. Ariel Pharmaceuticals, Inc. Acquires Novel Compound for Acute Migraine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... -- Uroplasty, Inc. (NASDAQ: UPI ), a medical ... proprietary products to treat voiding dysfunctions, will host ... March 12, 2015, beginning at 3:00 pm Central ... Minnetonka , Minnesota.     Rob ... host the meeting, which will feature a discussion ...
(Date:3/3/2015)... March 3, 2015 Although lung cancer is ... there are only 18 drugs in the market for ... Avastin are nearing their patent expiry in 2015 and ... offers vast potential that drug manufacturers are vying to ... small cell lung cancer (SCLC) and non-small cell lung ...
(Date:3/3/2015)... March 3, 2015 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") ... , Chief Executive Officer of ImmunoCellular, will present a ... Annual ROTH Conference on Tuesday, March 10, 2014 ... Laguna Niguel , CA.   ... presentation, please log on through a link located in ...
Breaking Medicine Technology:Uroplasty to Host Investor Meeting at Corporate Headquarters 2Uroplasty to Host Investor Meeting at Corporate Headquarters 3Uroplasty to Host Investor Meeting at Corporate Headquarters 4Uroplasty to Host Investor Meeting at Corporate Headquarters 5Uroplasty to Host Investor Meeting at Corporate Headquarters 6Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 2Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 3ImmunoCellular Therapeutics to Present at ROTH Conference on March 10th 2
... , CAMBRIDGE, Mass., Nov. 19 Ligon Discovery, Inc., ... drugs against high-value targets, today announced that it has ... The company will use the capital to complete its ... disease protein targets. With this investment, incTANK Ventures General ...
... , NEWPORT NEWS, Va., Nov. 19 Breast-Specific Gamma ... by two highly esteemed organizations for the fight against ... the American College of Surgeons. Both societies published articles ... for the early detection of breast cancer. , "These ...
Cached Medicine Technology:Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3
(Date:3/3/2015)... 03, 2015 Celestix Networks, the ... today announced the global availability of Celestix Cloud ... the world’s most deployed platform for DirectAccess and ... R2. This new release enables organizations to manage ... from a single HTML 5 web interface called ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Jack Coats, ... that Mr. William A. Breukelman has been named to ... completed development of the first fully integrated version of ... capable of analyzing the three-dimensional motion of the heart ... comparing the analysis at 15,300 points to the motion ...
(Date:3/3/2015)... 03, 2015 Using an “intelligent,” rather ... Medicare Part D prescription drug coverage plans could save ... new University of Pittsburgh Graduate School of Public Health ... the March issue of the journal Health Affairs and ... have saved more than $5 billion in its Part ...
(Date:3/3/2015)... Miami, FL (PRWEB) March 03, 2015 ... to be an international keynote presenter at the ... at the Melbourne Convention and Exhibition Centre March ... on Wednesday, March 11, at 11 am (Melbourne ... Emotions and Interests,” will discuss making each customer’s ...
(Date:3/3/2015)... A recent study of the correlation ... and radio host Sharon Kleyne has been saying for ... water in the body – is extremely widespread ... the US population. Kleyne further believes that research will ... all disease, including aging and stroke. , ...
Breaking Medicine News(10 mins):Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 2Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 3Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 3Health News:South Florida-based PureFormulas will discuss personalization at ecommerce Conference and Expo in Melbourne, Australia 2Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 2Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 3
... HealthDay Reporter , THURSDAY, Aug. 25 (HealthDay News) -- For kids, ... late and sleeping until noon: It also signals the beginning of ... Whether your child is a preschooler or a teen, some ... for parents is to know how to ease your children,s stress ...
... HealthDay Reporter , THURSDAY, Aug. 25 (HealthDay News) -- An ... finds that children,s vaccines are typically safe, with bad reactions ... problems. The IOM committee also agreed that there is ... later onset of conditions such as autism or type 1 ...
... the basis of new and effective treatments for ovarian ... and Portsmouth. The scientists are developing ... to stop cells from ovarian tumours growing. In initial ... from cancer patients. The extracts are complex mixtures ...
... 2011 -- Heart rate and blood pressure regulation may hold ... a new study by researchers at Wake Forest Baptist Medical ... as orthostatic intolerance (OI), which causes dizziness and occasional fainting ... debilitating chronic nausea in patients., "There seems to be a ...
... diagnostic imaging technique, physicians now have an objective test ... disease. Northwestern Memorial Hospital is among the first institutions ... imaging agent for assessment of movement disorders. Until now, ... forcing physicians to rely on clinical examinations to make ...
... An analysis of more than 1,000 research articles ... clearly associated with vaccines. A committee of experts ... scientific literature on possible adverse effects of vaccines found ... inflammation of the brain, and fainting -- that can ...
Cached Medicine News:Health News:Parents Can Ease Back-to-School Stress 2Health News:Parents Can Ease Back-to-School Stress 3Health News:U.S.-Mandated Report Finds Vaccines Safe for Kids 2Health News:U.S.-Mandated Report Finds Vaccines Safe for Kids 3Health News:U.S.-Mandated Report Finds Vaccines Safe for Kids 4Health News:Plants could pave the way for new ovarian cancer treatments 2Health News:Heart may hold key to unexplained nausea in youths 2Health News:New imaging test gives physicians better tool to diagnose Parkinson's disease 2Health News:New imaging test gives physicians better tool to diagnose Parkinson's disease 3Health News:Few health problems are caused by vaccines, IOM report finds 2Health News:Few health problems are caused by vaccines, IOM report finds 3
... glucuronide (3alpha-diol G) is the glucuronide ... of dihydrotestosterone (DHT) [1,2]. 3alpha-diol G ... 75% of the bioactivity of testosterone ... product of intracellular reduction of DHT, ...
... Activins are polypeptide hormones which ... (TGF-) superfamily. The TGF- superfamily is ... factors which control many aspects of ... (1). Other members incude TGF-s, bone ...
... Gla protein, is a vitamin K-dependent, calcium ... of the noncollagenous bone matrix [1,2,3]. Osteocalcin ... a small amount produced by odontoblasts in ... formation, newly synthesized osteocalcin is incorporated into ...
... binding protein-2 (IGFBP-2) is one of six ... which specifically bind and modulate the actions ... of IGFBP-2 for IGF-II is estimated to ... suggesting a role in regulation of IGF-II ...
Medicine Products: